Researchers have used a new 3D DNA mapping technique to analyze rare immune cells in the gut, identifying more than 100 genes that may influence the risk of developing Crohn's disease. The findings were reported by Technology Networks and other outlets, based on a study published in Nature.
The research focused on type 3 innate lymphoid cells (ILC3s), a scarce immune cell population involved in gut inflammation and immune responses. According to the reports, scientists at Imperial College London mapped the three-dimensional organization of DNA within these cells to understand how genetic risk factors for immune diseases operate at a molecular level.
The study's approach allowed researchers to examine how DNA regions interact within the nucleus of ILC3s. By analyzing these promoter interactions, they pinpointed specific genes that are activated in these cells and linked them to disease risk. The technique is notable because it opens up rare cell types to genetic research that was previously difficult to conduct, as noted by Research Horizons.
The findings suggest that the physical arrangement of DNA in ILC3s plays a role in determining which genes are expressed, and that disruptions in this organization could contribute to Crohn's disease and other autoimmune conditions. Phys.org reported that the work revealed new genes associated with autoimmune disease risk, expanding the list of potential targets for future therapies.
This research marks a step forward in understanding how genetic predisposition translates into disease at the cellular level. The identification of these specific genes provides a clearer picture of the biological pathways involved in Crohn's disease, which could inform future treatment strategies. Watch for follow-up studies that explore whether these genes can be targeted therapeutically in clinical settings.
